Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza (Pandemic)”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01003418
What this trial is testing

Study to Evaluate Safety and Immunogenicity of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children

Who this might be right for
Influenza
GlaxoSmithKline 8
Not applicableStudy completedNCT01056354
What this trial is testing

Respiratory Virus Outpatient Study (FLU 002 Plus)

Who this might be right for
Influenza and Other Novel Respiratory Viruses
University of Minnesota 11,719
Large-scale testing (Phase 3)WithdrawnNCT00866580
What this trial is testing

Evaluation of GSK Biologicals' Pandemic Influenza Vaccine

Who this might be right for
Influenza
GlaxoSmithKline
Testing effectiveness (Phase 2)Study completedNCT00976469
What this trial is testing

A/H1N1 Immunogenicity and Safety in Infants, Children and Adolescents

Who this might be right for
InfluenzaPandemic Influenza
Alachua Government Services, Inc. 400
Not applicableStudy completedNCT01000571
What this trial is testing

Immunogenicity and Safety of Inactivated H1N1 Swine-origin Influenza Monovalent Vaccine in Immunocompromised Children and Young Adults

Who this might be right for
H1N1 Pandemic Flu
St. Jude Children's Research Hospital 104
Early research (Phase 1)Study completedNCT06179446
What this trial is testing

Learn How Safe, Tolerable and Capable of Producing an Immune Response is, a Modified RNA Vaccine Against Pandemic Influenza

Who this might be right for
GrippeInfluenzaVaccines
Pfizer 157
Early research (Phase 1)Study completedNCT05397119
What this trial is testing

A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Pandemic Flu Vaccine in Healthy Adults

Who this might be right for
Influenza, Pandemic
BlueWillow Biologics 40
Early research (Phase 1)Study completedNCT00812019
What this trial is testing

Dose Ranging Study to Evaluate Immunogenicity and Safety of Adjuvanted or Non-adjuvanted Cell Culture-derived H5N1 Influenza Vaccine in Young Adults (18-40 Years Old)

Who this might be right for
Influenza
Seqirus 753
Early research (Phase 1)Study completedNCT02335164
What this trial is testing

Evaluate the Immunogenicity and Safety of a Pandemic Avian Influenza Vaccine in Adults

Who this might be right for
Influenza
Vaxine Pty Ltd 270
Testing effectiveness (Phase 2)Study completedNCT00430521
What this trial is testing

Safety & Immunogenicity of an Alternative Immunization Schedule of GSK Bio's Pandemic Influenza Vaccine (GSK1119711A)

Who this might be right for
InfluenzaInfluenza Vaccines
GlaxoSmithKline 512
Not applicableStudy completedNCT01037855
What this trial is testing

Observational Study of Safety of Flu Cell Culture Derived Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Vaccine

Who this might be right for
Novel Influenza A (H1N1)A New Flu Virus of Swine Origin
Novartis Vaccines 4,028
Early research (Phase 1)Looking for participantsNCT07111078
What this trial is testing

Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (SteMos1) With and Without ALFQ Adjuvant in Healthy Adults

Who this might be right for
Influenza PreventionPandemic Influenza Prevention
National Institute of Allergy and Infectious Diseases (NIAID) 56
Large-scale testing (Phase 3)Study completedNCT00971425
What this trial is testing

Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1)

Who this might be right for
Influenza
GlaxoSmithKline 145
Testing effectiveness (Phase 2)Study completedNCT06382311
What this trial is testing

Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults

Who this might be right for
Influenza, Human
GlaxoSmithKline 991
Testing effectiveness (Phase 2)Study completedNCT02229357
What this trial is testing

Evaluation of Priming Effects by PLAI Vaccine on the Subsequent Response to Inactivated H5N1 Vaccine

Who this might be right for
Avian Influenza
Mahidol University 60
Early research (Phase 1)Study completedNCT02480101
What this trial is testing

Reactogenicity, Safety and Immunogenicity of a LAIV H7N9 Influenza Vaccine

Who this might be right for
Influenza
Research Institute of Influenza, Russia 40
Large-scale testing (Phase 3)Study completedNCT00971100
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects From 6 Months to 17 Years of Age

Who this might be right for
Pandemic Influenza
Novartis Vaccines 752
Early research (Phase 1)Study completedNCT00136331
What this trial is testing

Study of a Pandemic Influenza Vaccine

Who this might be right for
Influenza
Seqirus 400
Post-approval studies (Phase 4)Study completedNCT01730378
What this trial is testing

Immunogenicity and Safety of PrepandrixTM in Korean Subjects Aged 18 to 60 Years Old

Who this might be right for
Influenza
GlaxoSmithKline 131
Early research (Phase 1)Ended earlyNCT00562237
What this trial is testing

Immunogenicity and Safety of Two Adjuvant Formulations of an Egg-Derived Pandemic Vaccine

Who this might be right for
Healthy Subjects
Solvay Pharmaceuticals 400
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation